This grant, the Antiviral Drug Discovery (AViDD) program, is for establishing multidisciplinary Centers focused on the accelerated discovery and development of novel antivirals. Its primary purpose is to combat coronaviruses (CoVs) and select RNA viruses identified with significant pandemic potential. Through this program, the National Institute of Allergy and Infectious Diseases (NIAID) aims to encourage the development of broad-spectrum antivirals, effective against multiple viral strains. Additionally, it seeks to advance innovative technologies applicable across various antiviral classes and create efficient platforms. The overarching goal is to significantly reduce the time and cost involved in creating new antiviral treatments, enhancing global preparedness for future viral outbreaks.
Opportunity ID: 334659
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-21-050 |
| Funding Opportunity Title: | Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 09, 2021 |
| Last Updated Date: | Jul 09, 2021 |
| Original Closing Date for Applications: | Oct 22, 2021 |
| Current Closing Date for Applications: | Oct 22, 2021 |
| Archive Date: | Nov 27, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Independent school districts Small businesses Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement solicits applications to establish the Antiviral Drug Discovery (AViDD) program of multidisciplinary Centers focused on discovery and development of antivirals against coronaviruses (CoVs) and select RNA viruses with pandemic potential. Through this program, NIAID will encourage the development of antivirals that are effective against multiple viruses, technologies that can be widely applied to improve classes of antivirals, and platforms that can reduce the time and cost of creating new antivirals. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-050.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268154 | Sep 22, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334659 RR_SF424_2_0-2.0.pdf
334659 PHS398_CoverPageSupplement_5_0-5.0.pdf
334659 RR_OtherProjectInfo_1_4-1.4.pdf
334659 PerformanceSite_2_0-2.0.pdf
334659 RR_KeyPersonExpanded_2_0-2.0.pdf
334659 PHS398_ResearchPlan_4_0-4.0.pdf
334659 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334659 PHS_Additional_IndirectCosts-1.0.pdf
334659 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
